Literature DB >> 1624388

The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems.

D A Mitchison1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1624388     DOI： 10.1093/jac/29.5.477

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  28 in total

1.  The stringent response of Mycobacterium tuberculosis is required for long-term survival.

Authors:  T P Primm; S J Andersen; V Mizrahi; D Avarbock; H Rubin; C E Barry
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

2.  Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis.

Authors:  Yanmin Hu; Anthony R M Coates; Denis A Mitchison
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

Review 3.  Surviving the acid test: responses of gram-positive bacteria to low pH.

Authors:  Paul D Cotter; Colin Hill
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056

Review 4.  Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.

Authors:  E Nuermberger; J Grosset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

Review 5.  Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors:  W J Burman; K Gallicano; C Peloquin
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

6.  Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.

Authors:  Justin J Wilkins; Radojka M Savic; Mats O Karlsson; Grant Langdon; Helen McIlleron; Goonaseelan Pillai; Peter J Smith; Ulrika S H Simonsson
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

7.  Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.

Authors:  Eric Nuermberger; Ian Rosenthal; Sandeep Tyagi; Kathy N Williams; Deepak Almeida; Charles A Peloquin; William R Bishai; Jacques H Grosset
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

8.  Exposure to antibiotics induces expression of the Mycobacterium tuberculosis sigF gene: implications for chemotherapy against mycobacterial persistors.

Authors:  T M Michele; C Ko; W R Bishai
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

9.  Individual Mycobacterium tuberculosis universal stress protein homologues are dispensable in vitro.

Authors:  S M Hingley-Wilson; K E A Lougheed; K Ferguson; S Leiva; H D Williams
Journal:  Tuberculosis (Edinb)       Date:  2010-06-11       Impact factor: 3.131

10.  13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.

Authors:  Mandeep S Jassal; Gueno G Nedeltchev; Jong-Hee Lee; Seong Won Choi; Viorel Atudorei; Zachary D Sharp; Vojo Deretic; Graham S Timmins; William R Bishai
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.